Influenza vaccination

On this page

Influenza Virus - The Shifty Shape-shifter

  • Virus: Enveloped, single-stranded RNA Orthomyxovirus with a segmented genome (8 segments).

  • Key Antigens: Hemagglutinin (HA) for entry, Neuraminidase (NA) for release.

  • Antigenic Drift:

    • Minor point mutations in HA/NA genes.
    • Allows evasion of host immunity, causing seasonal epidemics.
    • Occurs in both Influenza A and B.
  • Antigenic Shift:

    • Major, abrupt antigen change via genetic reassortment of RNA segments.
    • Creates new viral subtypes.
    • Leads to devastating pandemics.
    • Occurs in Influenza A only.

⭐ The segmented genome is the linchpin for antigenic shift. It allows Influenza A viruses from different species (e.g., avian, human) to exchange genes, creating a novel virus to which there is little population immunity.

Vaccine Types - The Annual Armor

  • Inactivated Influenza Vaccine (IIV - "Flu Shot")
    • Killed virus, administered intramuscularly (IM).
    • Safe for most, including infants >6 months, pregnant women, and the immunocompromised.
    • Includes standard-dose, high-dose (for ≥65y), and adjuvanted (for ≥65y) formulations to enhance immune response in the elderly.
  • Live Attenuated Influenza Vaccine (LAIV - "Nasal Spray")
    • Live, temperature-sensitive weakened virus; administered intranasally.
    • ⚠️ Contraindicated in pregnancy, immunocompromised individuals, and adults ≥50 years.
  • Recombinant Influenza Vaccine (RIV)
    • Produced via recombinant DNA technology; completely egg-free.
    • Indicated for individuals ≥18 years, especially those with severe egg allergies.

Parenteral vs. Nasal Vaccines: Pros and Cons

⭐ Most modern flu vaccines are quadrivalent, designed to protect against two influenza A viruses (an H1N1 and an H3N2) and two influenza B viruses from different lineages (Victoria and Yamagata).

ACIP Recommendations - The Rulebook

  • Annual vaccination is recommended for all persons aged ≥6 months who do not have contraindications.
  • Timing: Vaccinate by the end of October, before the peak of the influenza season.
  • Adults ≥65 years: Preferential use of higher-dose or adjuvanted influenza vaccines (e.g., Fluzone High-Dose Quadrivalent, Flublok Quadrivalent, or Fluad Quadrivalent).
  • Children (6 months-8 years): Require 2 doses (administered ≥4 weeks apart) during their first season of vaccination.

⭐ For individuals with a history of severe allergic reaction to eggs (e.g., anaphylaxis), any age-appropriate inactivated or recombinant influenza vaccine may be administered in a medical setting, supervised by a provider able to manage severe allergic reactions.

Contraindications - Red Flags & Risks

  • Absolute Contraindication:
    • History of severe allergic reaction (e.g., anaphylaxis) to a previous dose or any vaccine component.
  • Precautions (Proceed with caution):
    • History of Guillain-Barré Syndrome (GBS) within 6 weeks of a prior influenza vaccine dose.
    • Moderate-to-severe acute illness (defer until recovered).
  • Live Attenuated Vaccine (LAIV) Specific Contraindications:
    • Immunocompromised individuals & pregnant women.
    • Children aged 2-4 years with asthma.
    • Close contacts of severely immunosuppressed persons.

⭐ A history of egg allergy is no longer a contraindication. Patients with a history of severe allergic reaction to eggs (e.g., anaphylaxis) can receive any licensed influenza vaccine in a medical setting.

  • Annual vaccination is crucial due to antigenic drift (minor point mutations) in hemagglutinin (HA) and neuraminidase (NA) genes.
  • The inactivated (killed) vaccine is the most common type; the live attenuated intranasal vaccine is contraindicated in pregnancy and immunocompromised individuals.
  • Vaccine-induced immunity primarily targets the hemagglutinin (HA) antigen, which blocks viral entry into cells.
  • Universal vaccination is recommended for everyone ≥6 months of age annually.
  • Antigenic shift, a major genetic reassortment, can cause pandemics.

Practice Questions: Influenza vaccination

Test your understanding with these related questions

A 24-year-old woman with HIV infection comes to the physician for a follow-up examination. She has been inconsistently taking combined antiretroviral therapy for the past 5 years. She did not receive any childhood vaccinations because her parents were against them. During the consultation, the patient says that she wants to catch up on the missed vaccinations. Laboratory studies show a CD4+ T lymphocyte cell count of 180/mm3. Administration of the vaccine against which of the following agents should be avoided in this patient?

1 of 5

Flashcards: Influenza vaccination

1/10

What type of vaccine is the HAV vaccine?_____

TAP TO REVEAL ANSWER

What type of vaccine is the HAV vaccine?_____

Inactivated/killed

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial